CCRCC
Clinical trials for CCRCC explained in plain language.
Never miss a new study
Get alerted when new CCRCC trials appear
Sign up with your email to follow new studies for CCRCC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy offers hope for kidney cancer patients who relapsed
Disease control Not yet recruitingThis study tests whether combining two drugs, pembrolizumab and lenvatinib, can shrink or slow advanced kidney cancer in 108 adults whose cancer returned after prior pembrolizumab treatment. Participants receive the drug combination and are monitored for tumor response and side e…
Matched conditions: CCRCC
Phase: PHASE2 • Sponsor: Gruppo Oncologico Italiano di Ricerca Clinica • Aim: Disease control
Last updated May 06, 2026 16:03 UTC
-
New PET scan may spot hidden kidney cancer after treatment
Diagnosis Not yet recruitingThis study tests whether a special PET scan using 89Zr-girentuximab can detect kidney cancer that remains or comes back after initial treatment. Ten adults with clear cell renal cell carcinoma will receive the scan before and after standard cryoablation. The goal is to see if the…
Matched conditions: CCRCC
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Diagnosis
Last updated May 15, 2026 11:57 UTC